CATALOGO DEI PRODOTTI DELLA RICERCA

FERRARI, Sergio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.551
EU - Europa 8.821
AS - Asia 6.802
SA - Sud America 1.046
Continente sconosciuto - Info sul continente non disponibili 298
AF - Africa 194
OC - Oceania 31
Totale 27.743
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.343
RU - Federazione Russa 3.557
SG - Singapore 2.668
CN - Cina 2.113
GB - Regno Unito 1.516
IT - Italia 984
BR - Brasile 842
HK - Hong Kong 590
VN - Vietnam 581
SE - Svezia 566
FR - Francia 503
DE - Germania 450
IE - Irlanda 448
FI - Finlandia 326
KR - Corea 229
CA - Canada 118
BD - Bangladesh 105
IN - India 98
UA - Ucraina 96
AR - Argentina 81
JP - Giappone 64
ID - Indonesia 61
NL - Olanda 58
ZA - Sudafrica 58
PL - Polonia 57
BE - Belgio 53
TR - Turchia 49
ES - Italia 47
IQ - Iraq 40
MX - Messico 37
AT - Austria 30
AU - Australia 28
IR - Iran 28
NG - Nigeria 28
EC - Ecuador 27
CO - Colombia 23
LT - Lituania 21
VE - Venezuela 21
CL - Cile 20
TG - Togo 20
PK - Pakistan 19
SA - Arabia Saudita 18
MA - Marocco 16
UZ - Uzbekistan 16
AE - Emirati Arabi Uniti 14
EG - Egitto 14
JM - Giamaica 14
GR - Grecia 13
BJ - Benin 12
IL - Israele 12
JO - Giordania 12
LB - Libano 10
RO - Romania 10
TN - Tunisia 10
AL - Albania 9
CH - Svizzera 9
DO - Repubblica Dominicana 9
KE - Kenya 9
PY - Paraguay 9
BG - Bulgaria 8
CZ - Repubblica Ceca 8
PH - Filippine 8
PT - Portogallo 8
SY - Repubblica araba siriana 8
UY - Uruguay 8
CR - Costa Rica 7
HR - Croazia 7
KZ - Kazakistan 7
OM - Oman 7
BO - Bolivia 6
LV - Lettonia 6
MY - Malesia 6
PE - Perù 6
TW - Taiwan 6
KG - Kirghizistan 5
NP - Nepal 5
DZ - Algeria 4
GE - Georgia 4
LU - Lussemburgo 4
ML - Mali 4
NO - Norvegia 4
BA - Bosnia-Erzegovina 3
BY - Bielorussia 3
DK - Danimarca 3
HN - Honduras 3
HU - Ungheria 3
KH - Cambogia 3
NI - Nicaragua 3
PA - Panama 3
RS - Serbia 3
TT - Trinidad e Tobago 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AO - Angola 2
AZ - Azerbaigian 2
BB - Barbados 2
BH - Bahrain 2
BW - Botswana 2
CG - Congo 2
CI - Costa d'Avorio 2
GF - Guiana Francese 2
Totale 27.403
Salva come PNG Salva come JPEG
Città #
Singapore 1.364
Ashburn 1.350
Southend 1.233
Moscow 1.153
Chandler 1.003
Dallas 993
San Jose 989
Jacksonville 625
Hong Kong 580
Woodbridge 534
Dublin 432
Verona 432
Beijing 390
Council Bluffs 373
The Dalles 312
Ann Arbor 285
Houston 238
New York 238
Los Angeles 208
Ho Chi Minh City 188
Wilmington 169
Lawrence 163
Princeton 163
Jinan 126
Hanoi 116
Shenyang 116
Nanjing 112
Helsinki 107
Buffalo 95
Hebei 92
Munich 82
São Paulo 81
Santa Clara 77
Redmond 74
Sindelfingen 73
Redondo Beach 72
Tianjin 69
Dearborn 68
Columbus 62
Milan 60
Ningbo 55
Warsaw 52
Changsha 50
Hangzhou 49
Tokyo 49
Montreal 48
Chicago 47
Washington 47
Brussels 46
Guangzhou 45
London 45
Zhengzhou 45
Jakarta 44
Turku 43
Boardman 42
Nanchang 42
Orem 41
Seoul 41
Falls Church 39
Seattle 38
Frankfurt am Main 37
Haikou 37
Bologna 36
Brooklyn 36
Denver 35
Lancaster 35
Phoenix 35
Dong Ket 34
Rome 33
Taizhou 33
Johannesburg 31
Nuremberg 31
Haiphong 30
Redwood City 29
Stockholm 29
Taiyuan 29
Boston 28
Norwalk 27
Rio de Janeiro 27
Abuja 26
Chennai 26
Jiaxing 25
Paris 25
Atlanta 23
Fuzhou 23
Lappeenranta 23
San Francisco 23
Toronto 23
Adelaide 22
Kent 22
Belo Horizonte 20
Lomé 20
Amsterdam 19
Da Nang 19
Fairfield 19
Falkenstein 19
Poplar 19
Lanzhou 17
Florence 16
Curitiba 15
Totale 16.861
Salva come PNG Salva come JPEG
Nome #
Allelic origin of protease-sensitive and protease-resistant prion protein isoforms in Gerstmann-Sträussler-Scheinker Disease with the P102L mutation. 272
Complement-mediated demyelination in patients with IgM monoclonal gammopathy and polyneuropathy 264
A pediatric case of Miller Fisher syndrome with central involvement. 264
Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study 264
Autologous cellular vaccine overcomes cancer immunoediting in a mouse model of myeloma 260
Acute inflammatory demyelinating polyneuropathy as a manifestation of chronic lymphoproliferative disorder of NK cells. 256
Diagnosis of human prion disease using real-time quaking-induced conversion testing of olfactory mucosa and cerebrospinal fluid samples 248
Benign acute viral myositis in African migrants: a clinical, serological and pathological study. 243
Psychological Considerations in the Assessment and Treatment of Pain in Neurorehabilitation and Psychological Factors Predictive of Therapeutic Response: Evidence and Recommendations from the Italian Consensus Conference on Pain in Neurorehabilitation 242
Antisulfatide polyneuropathy: antibody-mediated complement attack on peripheral myelin 238
Cyclooxygenase 2, toll-like receptor 4 and interleukin 1beta mRNA expression in atherosclerotic plaques of type 2 diabetic patients. 236
Neurofilament light chain serum levels reflect disease severity in MOG-Ab associated disorders 234
A novel mutation of aprataxin associated with ataxia ocular apraxia type 1: Phenotypical and genotypical characterization 232
Antibody response against HERV-W env surface peptides differentiates multiple sclerosis and neuromyelitis optica spectrum disorder 228
A 49-year-old man with neuropsychiatric symptoms followed by progressive cognitive decline. 220
Mesenchymal stromal cells (MSCs) induce ex vivo proliferation and erythroid commitment of cord blood haematopoietic stem cells (CB-CD34+ cells) 218
Humoral immunity response to HERV-K/W differentiates between amyotrophic lateral sclerosis and other neurological diseases 215
A test for Creutzfeldt-Jakob disease using nasal brushings. 214
A 58-year-old man with B-cell chronic lymphocytic leukemia and multiple strokes 214
Anti-Ma-associated encephalomyeloradiculopathy in a patient with pleural mesothelioma. 213
Relevance of antibodies to myelin oligodendrocyte glycoprotein in CSF of seronegative cases 212
Alpha-synuclein seeds in olfactory mucosa of patients with isolated REM sleep behaviour disorder 211
Brentuximab vedotin: axonal microtubule's Apollyon 210
Analysis of mammalian scrapie protein by novel monoclonal antibodies recognizing distinct prion protein glycoforms: an immunoblot and immunohistochemical study at the light and electron microscopic levels. 209
Anti-N-methyl-d-aspartate receptor encephalitis causing a prolonged depressive disorder evolving to inflammatory brain disease. 208
Cytoskeletal changes in cultured human fibroblasts following exposure to 2,5-hexanedione 205
Detection of pathologic prion protein in the olfactory epithelium in sporadic Creutzfeldt-Jakob disease 205
Unusual case of solitary intraparenchymal brain plasmacytoma. 203
Assessing and treating pain in movement disorders, amyotrophic lateral sclerosis, severe acquired brain injury, disorders of consciousness, dementia, oncology and neuroinfectivology. Evidence and recommendations from the Italian Consensus Conference on Pain in Neurorehabilitation 202
RFC1 AAGGG repeat expansion masquerading as Chronic Idiopathic Axonal Polyneuropathy 201
High diagnostic accuracy of RT-QuIC assay in a prospective study of patients with suspected sCJD 198
Clinical and neurophysiological serial assessments of brentuximab vedotin-associated peripheral neuropathy 197
Antibody response against HERV-W in patients with MOG-IgG associated disorders, multiple sclerosis and NMOSD 193
Apraxia of eyelid closure in autopsy-confirmed vascular progressive supranuclear palsy. 191
Atypical BSE (BASE) transmitted from asymptomatic aging cattle to a primate. 190
Microglial and Neuronal TDP-43 Pathology in Anti-IgLON5-Related Tauopathy 187
Cauda equina syndrome caused by lumbosacral epidural lipomatosis. A case report. 187
Benign course of tumour-like multiple sclerosis. Report of five cases and literature review. 186
Nervous system: subclinical target of SARS-CoV-2 infection 186
Variable presentations of TTR-related familial amyloid polyneuropathy in seventeen patients. 185
Axonal neuropathy due to myelin protein zero mutation misdiagnosed as amyloid neuropathy 181
Neurological symptoms and axonal damage in COVID-19 survivors: are there sequelae? 179
Chronic fatigue syndrome: an emerging sequela in COVID-19 survivors? 178
Serology study after BTN162b2 vaccination in participants previously infected with SARS-CoV-2 in two different waves versus naïve 178
Intraspecies transmission of BASE induces clinical dullness and amyotrophic changes 177
Endothelial adhesion molecule expression is unaltered in the peripheral nerve from patients with AIDS and distal sensory polyneuropathy 176
Identification of distinct N-terminal truncated forms of prion protein in different Creutzfeldt-Jakob disease subtypes. 174
Neurological complications in adult allogeneic hematopoietic stem cell transplant patients: Incidence, characteristics and long-term follow-up in a multicenter series 174
Sural nerve biopsy: current role and comparison with serum neurofilament light chain levels 173
Serum and CSF neurofilament light chain levels in antibody-mediated encephalitis 171
Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: Clinical relevance of IgG isotype 171
Antibodies to MOG in CSF only: pathological findings support the diagnostic value 171
CIDP, CMT1B, or CMT1B plus CIDP? 170
Myelin uncompaction and axo-glial detachment in chronic ataxic neuropathy with monospecific IgM antibody to ganglioside GD1b 169
MOG antibody seropositivity in a patient with encephalitis: beyond the classical syndrome 168
Guillain-Barré syndrome and COVID-19: an observational multicentre study from two Italian hotspot regions 168
Polyneuropathy with anti-sulfatide and anti-MAG antibodies: Clinical, neurophysiological, pathological features and response to treatment. 167
Increased expression of the normal cellular isoform of prion protein in inclusion-body myositis, inflammatory myopathies and denervation atrophy 166
The original histological slides of Camillo Golgi and his discoveries on neuronal structure 164
Serum and cerebrospinal neurofilament light chain levels in patients with acquired peripheral neuropathies 161
Mycobacterium avium subspecies paratuberculosis and myelin basic protein specific epitopes are highly recognized by sera from patients with Neuromyelitis optica spectrum disorder 160
Human peripheral nerve macrophages in normal and pathological conditions 159
Role of HIV in the pathogenesis of distal symmetrical peripheral neuropathy 159
Cerebrospinal fluid markers in sporadic Creutzfeldt-Jakob disease. 157
Neurological complications of HIV infection in pre-HAART and HAART era: a retrospective study 157
Hypothalamic-Bulbar MRI hyperintensity in Anti-IgLON5 disease with serum-restricted antibodies: a case report and systematic review of literature 157
Anti-MOG-associated demyelinating disorders: two sides of the same coin 156
Late presentation of NMOSD as rapidly progressive leukoencephalopathy with atypical clinical and radiological findings 154
Peripheral nerve vasculitis: a clinico-pathological study 152
Cognitive Profile in Adult Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: A Comparative Study With Multiple Sclerosis 151
GABA(A) receptor autoimmunity after alemtuzumab treatment for multiple sclerosis 151
Phosphorylated 14-3-3zeta protein in the CSF of neuroleptic-treated patients 150
Diagnostic features of initial demyelinating events associated with serum MOG-IgG 150
Autoimmune movement disorders complicating treatment with immune checkpoint inhibitors 149
Oligoclonal bands: clinical utility and interpretation cues 149
Epileptic seizures of suspected autoimmune origin: a multicentre retrospective study 147
Frequency and clinical correlates of anti-neural IgM antibodies in neuropathy associated with IgM monoclonal gammopathy 146
Further evidence that mutations in FGD4/frabin cause Charcot-Marie-Tooth disease type 4H. 146
Pentraxin-3 and VEGF in POEMS syndrome: A 2-year longitudinal study. 146
Clinical Neuropathology image 1-2018: Golgi silver staining, the black reaction 146
Progressive multifocal leukoencephalopathy in a patient with Good's syndrome. 145
Autoimmune encephalitis misdiagnosis and mimics 144
Is there a correlation between MOGAD and SARS-CoV-2 infection? 143
Primary neurolymphomatosis as clinical onset of chronic lymphocytic leukemia 141
Inter-center agreement in the interpretation of oligoclonal bands 141
ACUTE ONSET OF PARANODOPATHY ASSOCIATED WITH ANTI-CASPR1 ANTIBODIES AND PROMINENT CRANIAL NERVES INVOLVEMENT 140
HIV-associated PML presenting as epilepsia partialis continua 140
HCV-related nervous system disorders. 140
Investigating paraneoplastic aquaporin-4 positive neuromyelitis optica spectrum disorder through a data-driven approach 138
Demyelinating polyradiculoneuritis following Coxiella burnetti infection (Q fever) 137
GFAP as a marker of astrocytic damage correlated with medication overuse in migraine 136
Novel prion protein conformation and glycotype in Creutzfeldt-Jakob disease 136
Hepatitis C virus-associated neurocognitive and neuropsychiatric disorders: Advances in 2015 135
La guaina mielinica causa di neuropatia. Identificazione delle radicolonevriti demielinizzanti. 133
Identification of a second bovine amyloidotic spongiform encephalopathy: molecular similarities with sporadic Creutzfeldt-Jakob disease. 132
Viral encephalitis: etiology, clinical features, diagnosis and management. 131
A novel cell-based immunofluorescence assay for the detection of autoantibodies to myelin-associated glycoprotein 131
Clearance of 14-3-3 protein from cerebrospinal fluid heralds the resolution of bacterial meningitis. 130
Risk of disease relapse following COVID-19 vaccination in patients with AQP4-IgG-positive NMOSD and MOGAD 130
Serum Biomarker Profiles Discriminate AQP4 Seropositive and Double Seronegative Neuromyelitis Optica Spectrum Disorder 129
Totale 17.951
Salva come PNG Salva come JPEG
Categoria #
all - tutte 101.706
article - articoli 98.813
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.893
Totale 203.412
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.407 0 530 5 189 31 70 19 64 50 54 119 276
2022/20232.874 203 294 265 490 226 706 33 201 323 23 72 38
2023/20241.552 67 101 147 166 148 350 66 92 17 86 211 101
2024/20254.074 242 270 147 639 191 123 225 223 648 306 336 724
2025/202612.198 841 862 887 1.929 3.036 787 1.075 728 918 643 197 295
2026/2027430 164 266 0 0 0 0 0 0 0 0 0 0
Totale 27.743